WASHINGTON - Seniors who switch between low-cost generic drugs and the original products based on who's footing the bill are likely driving up the cost of the government's Medicare drug plan, according to a new study.
|
|
||
|
|
Comments
Admin's note: Participants in the discussion of this weblog entry should note the site's moderation policy. |
|
